If you have diabetes and take insulin, Medicare CGM coverage in 2026 could replace painful fingersticks with a small sensor that tracks your glucose around the clock — and Part B now covers it for far more seniors than it did just a few years ago. A continuous glucose monitor (CGM) reads your interstitial glucose every few minutes, shows trends and direction-of-change arrows, and can alert you before a dangerous low. After CMS broadened the rules, eligibility no longer depends on multiple daily injections. This guide explains who qualifies, what you will pay, which devices are covered, and the one visit you must complete first.
Table of Contents
- Does Medicare cover a CGM in 2026?
- Who qualifies under the expanded rules
- Which CGMs Medicare covers
- What you will pay
- Why a CGM matters for older adults
- Frequently asked questions
Does Medicare Cover a CGM in 2026?
Yes. Medicare Part B covers therapeutic continuous glucose monitors as durable medical equipment (DME) for beneficiaries who meet the coverage criteria. The pivotal change came when CMS dropped the old requirement that you inject insulin three or more times a day. Today, anyone treated with insulin — any type, any dose — can qualify, and so can certain people who do not use insulin but have a history of dangerous low blood sugar. The covered supplies include the sensors and transmitter that make the system work.
Who Qualifies Under the Expanded Rules
You generally qualify for a Medicare-covered CGM if you have diabetes and meet one of the pathways below, confirmed by your treating practitioner.
| Pathway | What it requires |
|---|---|
| Insulin-treated | You are treated with insulin of any type or amount |
| Hypoglycemia history | Recurrent level 2 lows (under 54 mg/dL) despite treatment changes, or one level 3 event needing another person’s help |
| Required visit | An in-person or telehealth visit within 6 months before the order to confirm eligibility |
| Ongoing care | Routine follow-up visits to keep using the device under coverage |
The hypoglycemia pathway is the underused one. Many older adults on sulfonylureas (such as glipizide or glyburide) are not on insulin but still experience dangerous lows — and those drugs are on the Beers Criteria list of medications to use cautiously in seniors precisely because of that risk. If that is you, ask your doctor whether the documented-hypoglycemia route applies.
Which CGMs Medicare Covers
Several standalone CGM systems are covered when supplied through an enrolled DME provider. The most commonly dispensed are the Dexcom G6 and G7, the Abbott FreeStyle Libre 2 and Libre 3, and the implantable Eversense system. Your choice often comes down to wear time, smartphone compatibility, and whether you want a sensor you can replace yourself versus an implant your doctor places.
| System | Sensor wear | Notable feature |
|---|---|---|
| Dexcom G7 | About 10 days | Customizable low/high alerts, small profile |
| FreeStyle Libre 3 | About 14 days | Longest wear, real-time readings to phone |
| Eversense | Up to 6 months | Implanted sensor, removable transmitter |
What You Will Pay
Because a CGM is billed under Part B as DME, you typically pay 20% of the Medicare-approved amount after meeting the annual Part B deductible, which is $283 in 2026. There is no separate “preventive” exemption here — the deductible and coinsurance both apply. The good news: a Medigap plan can cover that 20%, and people with both Medicare and Medicaid often pay little or nothing. Getting supplies from a Medicare-enrolled pharmacy or DME supplier that accepts assignment is essential to avoid balance billing.
Why a CGM Matters for Older Adults
The 2026 American Diabetes Association Standards of Care emphasize avoiding hypoglycemia in older adults, recommending that time spent below 70 mg/dL stay under 1% for those using CGM. That is exactly what continuous monitoring helps you see. Instead of a single fingerstick snapshot, a CGM shows whether your glucose is rising, falling, or holding steady — and it can sound an alarm overnight, when many severe lows happen unnoticed. For seniors at risk of falls, confusion, or hospitalization from hypoglycemia, that early warning is the core benefit. CGMs also reduce the burden of multiple daily fingersticks, which matters for anyone with arthritis, neuropathy, or vision loss that makes lancing difficult.
Frequently Asked Questions
I have type 2 diabetes but don’t take insulin. Can I get a CGM?
Possibly. If you are not on insulin, you can still qualify through the hypoglycemia pathway — documented recurrent or severe low blood sugar episodes. Otherwise, Medicare generally limits coverage to insulin-treated beneficiaries. Talk with your doctor about which pathway fits your records.
Does Medicare cover the CGM sensors every month?
Yes. Once you qualify, the ongoing sensors and transmitter are covered supplies under Part B, subject to the same 20% coinsurance. You will need periodic follow-up visits to maintain coverage.
What is the difference between Part B and Part D here?
The CGM device and sensors are covered under Part B as DME. Insulin itself is usually covered under Part D (or Part B if used with a pump), and in 2026 covered insulin is capped at $35 per month. Knowing which part pays prevents billing confusion.
Can I use my smartphone with a Medicare CGM?
Yes. Medicare allows use of a compatible smartphone app with covered CGMs, though you can also use the dedicated receiver if you prefer not to rely on a phone.
How to Get Started With Your Doctor
Getting a covered CGM follows a predictable path, and knowing the steps prevents delays. Start by scheduling a visit specifically to discuss glucose monitoring — bring your medication list and, if you have them, recent logs of any low blood sugar episodes, including dates and symptoms. Your practitioner documents that you meet the criteria, then sends a prescription to a Medicare-enrolled pharmacy or durable medical equipment supplier that accepts assignment. That last detail matters: ordering through a non-enrolled supplier is a frequent reason beneficiaries get billed far more than the 20% coinsurance.
If you are in a Medicare Advantage plan rather than Original Medicare, the same coverage rules apply, but your plan may require a specific in-network supplier or prior authorization. Call the number on your card and ask which suppliers are in-network before your prescription is sent. Finally, plan for the learning curve. A CGM produces a flood of data, and the goal is not to react to every reading but to spot patterns — overnight lows, post-meal spikes, the effect of a walk after dinner. Many seniors find a short session with a diabetes educator, also often covered, turns the device from overwhelming into genuinely useful.
Will a CGM work if I have poor eyesight or arthritis?
That is one of its biggest advantages for seniors. A CGM removes the need to lance a fingertip and read a tiny meter screen many times a day. Readings appear in large numbers on a phone or receiver, and the device can sound an audible alarm for highs and lows, which helps people with low vision or limited hand dexterity stay safe.
Related Articles You May Find Helpful
- Medicare 2026: The Complete Guide for Seniors
- Diabetes in Seniors 2026: New ADA Standards That Change Your Care
- Diabetic Neuropathy Treatment 2026: 8 Options That Actually Work
- Can Seniors Reverse Type 2 Diabetes? 2026 Science Says Yes
- Prediabetes in Seniors 2026: How to Reverse It Before It’s Too Late
Sources
- Medicare.gov — Continuous Glucose Monitors Coverage
- CMS — Medicare Coverage of Diabetes Supplies (MLN, February 2026)
- American Diabetes Association — Older Adults: Standards of Care in Diabetes 2026
This article is educational and not a substitute for medical advice. See our Medical Disclaimer and Editorial Guidelines.
